Clinical Trial: Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07884721) titled 'Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer' on Sept. 30.

Brief Summary: This randomized, multicenter, open-label clinical study will evaluate whether adding the Fasten Onco digital therapy, which supports a fasting-mimicking diet (FMD), to standard neoadjuvant treatment can reduce treatment-related fatigue in adult women with stage II or III triple-negative breast cancer.

Participants will be randomly assigned to receive either standard neoadjuvant treatment alone or standard neoadjuvant treatment together with the Fasten Onco program. Participants assigned to Fasten Onco will follow ...